R-59494

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameR-59494
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockersVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelSodium channels
Therapy Area/IndicationsMyocardial IschemiaArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutical Ltd
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A